Literature DB >> 20058164

Neuroproteomic methods in spinal cord injury.

Anshu Chen1, Joe E Springer.   

Abstract

Spinal cord injury (SCI) is a major public health problem with no known effective treatment. Traumatic injury to the spinal cord initiates a host of pathophysiological events that are secondary to the initial insult leading to neuronal dysfunction and death; yet, the molecular mechanisms underlying its dysfunction are poorly understood. Furthermore, while use of imaging methods (e.g., computed tomography scans and magnetic resonance imaging) may help define injury severity and location, they do not elucidate biological mechanisms of SCI progression. The lack of comparable biomarkers for monitoring SCI makes accurate diagnosis and evaluation of SCI progression difficult. Spinal cord contusion is an extensively used SCI model in rats that best represents the etiology of SCI in humans. In this chapter, we describe a two-dimensional (2D) gel electrophoresis-based proteomic approach to investigate the injury-related differences in the proteome and phosphoproteome of spinal cord lesion epicenter at 24 h after spinal cord contusion in rats. The purpose of this study is to elucidate the mechanisms of acute spinal cord dysfunction, as well as discover novel biomarker candidates to evaluate the biological mechanisms of SCI progression and the injury severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20058164     DOI: 10.1007/978-1-59745-562-6_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

2.  Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics.

Authors:  Stephane Belin; Homaira Nawabi; Chen Wang; Shaojun Tang; Alban Latremoliere; Peter Warren; Hubert Schorle; Ceren Uncu; Clifford J Woolf; Zhigang He; Judith A Steen
Journal:  Neuron       Date:  2015-04-30       Impact factor: 17.173

Review 3.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

4.  Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats.

Authors:  Firas H Kobeissy; Joy D Guingab-Cagmat; Zhiqun Zhang; Ahmed Moghieb; Olena Y Glushakova; Stefania Mondello; Angela M Boutté; John Anagli; Richard Rubenstein; Hisham Bahmad; Amy K Wagner; Ronald L Hayes; Kevin K W Wang
Journal:  Front Neurol       Date:  2016-11-22       Impact factor: 4.003

Review 5.  Serum and Cerebrospinal Fluid Levels of S-100β Is A Biomarker for Spinal Cord Injury; a Systematic Review and Meta-Analysis.

Authors:  Gholamreza Faridaalee; Fatemeh Keyghobadi Khajeh
Journal:  Arch Acad Emerg Med       Date:  2019-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.